Showing 1,559 results

Filters Content type: News, Editors' picks, About HIV Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Pharmaceutical industry

EPO Upholds Gilead Patent On Hep C Medicines, But In Amended Form

Editor's pick
Intellectual Property Watch
16 September 2018
Pharmaceutical industry

Groups Call for End to Gilead’s Unwarranted Hepatitis C Drug Monopoly in Europe

Editor's pick
MSF press release
11 September 2018
Pharmaceutical industry

CJEU Ruling on Truvada recalls ‘evergreening’ goes against public health interests

Editor's pick
Medicines Law & Policy
10 September 2018
Pharmaceutical industry

Chasing top HIV players, Merck scores FDA approval for 2 new drugs

Editor's pick
FiercePharma
1 September 2018
New & experimental HIV treatments

Should Gilead Be Worried About This New Monthly HIV Medication?

Editor's pick
Motley Fool
16 August 2018
Pharmaceutical industry

Gilead Said PrEP To Prevent HIV Was 'Not A Commercial Opportunity.' Now It's Running Ads For It

Editor's pick
Forbes Magazine
7 August 2018
Pharmaceutical industry

Mylan, lambasted for EpiPen price hikes, complains of overpriced anti-HIV drugs in the United States

Editor's pick
Science
7 August 2018
Pharmaceutical industry

Court of Justice of the European Union clarifies ‘basic patent’ meaning in SPC dispute

Editor's pick
Life Sciences Intellectual Property Review
26 July 2018
Pharmaceutical industry

HIV drug may be more affordable after European court ruling

Editor's pick
The Journal
26 July 2018
New & experimental HIV treatments

The 2018 Pipeline Report

Editor's pick
TAG
24 July 2018
Pharmaceutical industry

Gilead's HIV Franchise Under Assault As It Stares Down Paradigm-Changing Drug

Editor's pick
Seeking Alpha
18 July 2018
Pharmaceutical industry

How Big Pharma Was Captured by the One Percent

Editor's pick
New Republic
2 July 2018
PrEP

Finns buying HIV prevention drugs from Germany because they're cheaper

Editor's pick
YLE
30 June 2018
Behaviour change interventions

“I’m on the Pill” PrEP Ads Begin Airing on National TV

Editor's pick
Poz
29 June 2018
New & experimental HIV treatments

European Commission Grants Marketing Authorization for Gilead’s Biktarvy® (Bictegravir, Emtricitabine, Tenofovir Alafenamide) for the Treatment of HIV-1 Infection

Editor's pick
Gilead press release
25 June 2018
Pharmaceutical industry

GSK takes billion-dollar drug fight with Gilead to top AIDS meeting

Editor's pick
Reuters
25 June 2018
Pharmaceutical industry

Glaxo Venture's Lofty Goal in HIV: Eclipse Gilead as Top Player

Editor's pick
Bloomberg
21 June 2018
PrEP

#BREAKTHEPATENT

Editor's pick
breakthepatent.org
20 June 2018
New & experimental HIV treatments

GSK's two-drug HIV treatment meets main goal in late stage studies

Editor's pick
Reuters
15 June 2018
PrEP

With TV ads, drugmaker Gilead brings HIV prevention drug out of the closet

Editor's pick
NBC News
31 May 2018
Generic medicines

EU makes it easier for companies to produce generic medicines for export

Editor's pick
Reuters
29 May 2018
Pharmaceutical industry

AIDS Healthcare Foundation files two lawsuits against Gilead

Editor's pick
The Bay Area Reporter
21 May 2018
Access to healthcare

Collective Efforts By Civil Society Groups Bar The Way To Hepatitis C Patents

Editor's pick
Intellectual Property Watch
14 May 2018
Side effects

Is Gilead’s Entire HIV Enterprise Built on a False Promise?

Editor's pick
Poz
10 May 2018